Philippe Matthews Show Guru Advice, Author Reviews, Tech Reviews, Entertainment News

When chemical engineer Mark Davis' wife was diagnosed with cancer, he took his skills to develop a new and better treatment to fight her disease. Dr.

Twenty years ago, basketball legend Earvin "Magic" Johnson announced he was HIV- positive. Sports Illustrated senior writer Jack McCallum spoke to the "Early Show" anchors about Johnson's battle with the disease.

The new drug Kalydeco is being hailed as a breakthrough in the treatment of cystic fibrosis, targeting the underlying genetic cause of the disease decreasing the symptoms. Dr. Jon LaPook reports.

People with an uncommon form of cystic fibrosis started gaining weight and were better able to breathe than their untreated counterparts after just two weeks on an experimental drug, according to a study published November 2 in The New England Journal of Medicine . If approved by the U.S.

Hopes for new Alzheimer's drugs that would slow or stop the disease's inexorable decline have repeatedly foundered in recent years. Large pharmaceutical companies, which have pushed ahead with drugs that stop the buildup of toxic proteins that damage and kill brain cells, have reported a recurring string of bad news.

As many as 35 million people worldwide have Alzheimer's disease, the most common form of dementia among adults over 60 years of age. That figure could reach 115 million by 2050 , concludes the nonprofit Alzheimer's Disease International .

By David Cyranoski of Nature magazine Two of the largest studies yet carried out on the genetics of schizophrenia in Chinese populations have turned up three genetic loci, or chromosomal regions, previously not known to be related to the disease.

By David Cyranoski of Nature magazine Two of the largest studies yet carried out on the genetics of schizophrenia in Chinese populations have turned up three genetic loci, or chromosomal regions, previously not known to be related to the disease. These genome-wide association studies (GWAS), done independently and published in Nature Genetics on October 30, also begin to redress a geographical imbalance: until now, GWAS have focused mainly on Western populations.

By David Cyranoski of Nature magazine Two of the largest studies yet carried out on the genetics of schizophrenia in Chinese populations have turned up three genetic loci, or chromosomal regions, previously not known to be related to the disease. These genome-wide association studies (GWAS), done independently and published in Nature Genetics on October 30, also begin to redress a geographical imbalance: until now, GWAS have focused mainly on Western populations

A fungus known as Geomyces destructans is indeed responsible for the dusting of white across bat noses and wings that has wiped out entire populations of the flying mammals, new research shows. By purposefully infecting healthy bats with the fungus--and confirming that seemingly healthy "control" bats from the same population did not get sick from a prior but hidden fungal infection--microbiologist David Blehert of the U.S.

A vaccine originally intended to prevent cervical cancer in girls should be given to boys as well, an advisory panel for the Centers for Disease Control and Prevention (CDC) said today (Oct. 25). The panel voted to recommend the human papillomavirus (HPV) vaccine be given to boys ages 11 to 12.

Prevention magazine Contributing Editor Dr. Holly Phillips speaks to the "Early Show" anchors about the health dangers of musician Barry Manilow's heart condition, atrial fribrillation, and how the disease is treated.

Steve Jobs was a rare case, right down to his death. Announced Wednesday, Jobs's death from "complications of pancreatic cancer" only hints at the vast complexity of the disease to which he succumbed at the age of 56.

Steve Jobs, the co-founder of Apple , died Wednesday at age 56. The cause was pancreatic cancer. Jobs had been battling cancer for at least 6 years, telling his employees in 2004 that he was being treated for the disease, and undergoing a l iver transplant in 2009.

A new study, called the DIAN study, is following multiple generations of family members across the globe with early-onset Alzheimer's disease. CBS News contributor Priya David Clemens reports on a Seattle family that is providing never-before insights into the disease's first signs